FindTrial
Sign In

Assessment of dry eye disease in systemic lupus erythematosus patients

Assessment of dry eye disease in systemic lupus erythematosus patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071965
Enrollment
Unknown
Registered
2023-05-30
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

systemic lupus erythematosus

Interventions

SLE:none
Control group:None

Sponsors

The Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: SLE patients satisfied the European League Against Rheumatism(EULAR) and the American College of Rheumatology(ACR) for the classification of SLE

Exclusion criteria

Exclusion criteria: (1)history of eye surgical procedures;(2)history of diseases affecting ocular surface conditions;(3)current and past contact lens wearers;(4) The time of using visual display terminal was equal to or more than 8 hours each day.

Design outcomes

Primary

MeasureTime frame
Ocular Surface Disease Index (OSDI) ;Tear meniscus height(TMH) ;Non-invasive Keratograph tear breakup time(NIKBUT) ;Objective scatter index (OSI) ;Lipid layer thickness(LLT);Corneal fluorescein score(CFS) ;Schirmer?test(S?T) ;meibomian gland dropout score;meibomian gland secretion score;eyelid margin score;—

Countries

China

Contacts

Public ContactGuoling Chen

The Second Hospital of Shandong University

sdey1777@163.com+86 176 6008 3136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026